Table 1.
Characteristics | Univariate analysis |
Multivariate analysis |
||
---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | |
Age | 1.02 (1.01-1.04) | <.001 | 1.03 (1.02-1.04) | <.001 |
Gender | ||||
Female | Reference | |||
Male | 0.76 (0.57-1.03) | .07 | ||
Clinical stage | ||||
Stage I | Reference | |||
Stage II & Stage III & Stage IV | 1.11 (0.95-1.30) | .19 | ||
T stage | ||||
T1 | Reference | |||
T2 & T3 & T4 | 1.10 (0.95-1.27) | .22 | ||
N stage | ||||
N0 | Reference | |||
N1 & N2 & N3 | 1.18 (1.01-1.37) | .04 | 1.23 (1.05-1.44) | <.01 |
M stage | ||||
M0 | Reference | |||
M1 | 4.50 (1.66-12.23) | <.01 | 6.73 (2.73-18.64) | <.001 |
Histologic grade | ||||
G1 | Reference | |||
G2 & G3 & G4 | 1.10 (0.89-1.36) | .37 | ||
CD8 T | 0.01 (0.001-0.08) | <.001 | 0.003 (0.0003-0.03) | <.001 |
Macrophage | 6.23 (1.10-35.42) | .04 | 3.97 (0.70-22.35) | .12 |